A comprehensive evaluation of potentially significant drug-drug, drug-herb, and drug-food interactions among cancer patients receiving anticancer drugs

AA Koni, MA Nazzal, BA Suwan, SS Sobuh… - BMC cancer, 2022 - Springer
Introduction During the cancer treatment path, cancer patients use numerous drugs,
including anticancer, supportive, and other prescribed medications, along with herbs and …

Frequency, severity, and factors associated with clinically significant drug-drug interactions among patients with cancer attending Mbarara Regional Referral Hospital …

B Luzze, B Atwiine, HM Lugobe, TM Yadesa - BMC cancer, 2022 - Springer
Background Cancer is a major public health problem with pharmacotherapy being the
cornerstone of its management. Cancer patients receive multiple drugs concurrently risking …

Role of the Pharmacist in the Management of Polypharmacy and Drug Interactions in the Elderly Patient with Chemotherapy

SMS de Souza, JCS Soares… - Current Cancer …, 2024 - ingentaconnect.com
Current Cancer Therapy Reviews Page 1 Current Cancer Therapy Reviews ISSN:1573-3947
eISSN:1875-6301 SCIENCE BENTHAM Silvania Maria Saldanha de Souza 1 , José Cleberson …

Drug-related problems among esophageal, gastric and colorectal cancer patients at the National and referral hospital in Kenya

A Degu, PN Karimi, SA Opanga… - Journal of Oncology …, 2024 - journals.sagepub.com
Introduction Cancer therapy has remarkable potential for drug-related problems due to the
high cytotoxicity and narrow therapeutic index of most anti-neoplastic regimens. However …

[HTML][HTML] Potential drug–drug interaction and its determinants among patients with cancer receiving chemotherapy in oncology centres of Northwest Ethiopia: an …

SA Wondm, FB Tamene, K Gubae, SB Dagnew… - BMJ open, 2023 - ncbi.nlm.nih.gov
Original research: Potential drug–drug interaction and its determinants among patients with
cancer receiving chemotherapy in oncology centres of Northwest Ethiopia: an institutional-based …

Polypharmacy and potentially-inappropriate medications are prevalent in the elderly cancer patients receiving systemic cancer therapy and they co-relate with …

C Bandidwattanawong, P Rattanaserikulchai… - BMC geriatrics, 2023 - Springer
Objectives Cancer is the disease of the ageing. Most of the elderly cancer patients have pre-
existing illnesses requiring complexity of medical care. Excessive medications would lead …

TOP-PIC: a new tool to optimize pharmacotherapy and reduce polypharmacy in patients with incurable cancer

I Strassl, A Windhager, S Machherndl-Spandl… - Journal of Cancer …, 2023 - Springer
Purpose Polypharmacy is a significant problem in patients with incurable cancer and a
method to optimize pharmacotherapy in this patient group is lacking. Therefore, a drug …

[HTML][HTML] Detection of potential drug-drug interactions among ovarian cancer patients in a tertiary care teaching hospital in South India-A retrospective approach

KB Rawal, UV Mateti, V Shetty, MK Unnikrishnan… - … and Global Health, 2023 - Elsevier
Background Potential drug-drug interactions (pDDIs) can alter therapeutic efficacy, involve
adverse reactions, and generate novel responses not elicited when either agent is used …

The Prevalence of Drug-Drug Interactions and Reported Therapy Related Side Effects in Oncology Out-Patients

RM Umar, ZY Can, E Güven, EK Koçberber… - Clinical and …, 2023 - dergipark.org.tr
Objective: The use of multiple medications in cancer patients is unavoidable; thus, adverse
drug-drug interactions are frequent. This study aims to assess the prevalence of potential …

Polypharmacy in the elderly cancer patients receiving systemic therapy is associated with more unpredicted hospitalizations.

C Bandidwattanawong, P Rattanaserikulchai… - 2023 - researchsquare.com
Objectives: Cancer is the disease of the ageing. Most of the elderly cancer patients have pre-
existing illnesses requiring complexity of medical care. Excessive medications would lead …